Thermo Fisher Posts Q3 EPS of $4.64
TMO sits 59% above its 52-week low of $435.27.
Summary
Thermo Fisher reported third-quarter adjusted EPS of $6.68, up 15%, on revenue of $12.14B, up 9%, with organic revenue up 6% and an adjusted operating margin of 24.5%. Net income was $1.72B. The adjusted EPS came in above the IBES estimate of USD 6.4. Context matters here: Q2 came in at $6.03 adjusted EPS on $11.99B revenue, up 10% year over year, with management flagging strengthening customer activity across end markets. The stock sits near its 52-week high of $704, so expectations are already elevated and the full release — segment detail and any change to full-year outlook — will decide direction.
At the time of this announcement, TMO was trading at $690.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $254.2B. The 52-week trading range was $435.27 to $704.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.